Literature DB >> 9331143

Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes.

H X Xia1, N J Talley, C T Keane, C A O'Morain.   

Abstract

Recurrence of Helicobacter pylori infection after successful eradication occurs and is associated with relapse of gastroduodenal diseases. The aims of this paper were to assess the incidence and identify the nature and possible causes of recurrence of the infection. A broad-based Medline search was performed to identify all related publications addressing recurrence of the infection between 1986 and 1995. The 12-month recurrence rate varied among the different studies from 0 to 41.5%. A few studies showed 18- to 24-month recurrence rates, which ranged between 0 and 21.4%. Limited data, obtained using molecular fingerprinting techniques, have shown that in most cases recurrence is due to recrudescence of the original strain; a few cases appear to be due to reinfection with a new strain. Recrudescence is most likely during the first 12 months after apparent eradication. Despite the high sensitivity and specificity of the available individual tests for detecting H. pylori infection in untreated patients, no technique alone is sensitive enough to monitor eradication when the four-week-rule definition for eradication is used. A combination of two or more techniques increases sensitivity. Sensitivity and specificity are increased when biopsies are taken from both gastric antrum and corpus. The best treatments have the lowest recurrence rates and recurrence is rare when the eradication rate is over 90%. Individual susceptibility and reexposure to H. pylori are suggested as two major causes of reinfection.

Entities:  

Mesh:

Year:  1997        PMID: 9331143     DOI: 10.1023/a:1018827322470

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  143 in total

Review 1.  Epidemiology of Campylobacter pylori infection.

Authors:  D Y Graham; E Adam; P D Klein; D J Evans; D G Evans; S L Hazell; L C Alpert; P A Michaletz; H H Yoshimura
Journal:  Gastroenterol Clin Biol       Date:  1989

2.  Blood group antigens and Helicobacter pylori infections.

Authors:  A W Smith; S Aathithan; E G Power; Y Abdulla
Journal:  Lancet       Date:  1994-02-26       Impact factor: 79.321

Review 3.  Helicobacter pylori.

Authors:  B J Marshall
Journal:  Am J Gastroenterol       Date:  1994-08       Impact factor: 10.864

4.  Evidence for the occurrence of the same strain of Campylobacter pylori in the stomach and dental plaque.

Authors:  B Shames; S Krajden; M Fuksa; C Babida; J L Penner
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

5.  Efficacy of omeprazole combined with antibiotics for Helicobacter pylori eradication and duodenal ulcer recurrence.

Authors:  M Lazzaroni; G Maconi; S Bargiggia; M Minguzzi; G Bianchi Porro
Journal:  Eur J Gastroenterol Hepatol       Date:  1995-02       Impact factor: 2.566

6.  Causal role of Helicobacter pylori in peptic ulcer relapse.

Authors:  M Asaka; T Ohtaki; M Kato; M Kudo; T Kimura; T Meguro; S Horita; K Inoue
Journal:  J Gastroenterol       Date:  1994-07       Impact factor: 7.527

7.  Conventional cleaning and disinfection techniques eliminate the risk of endoscopic transmission of Helicobacter pylori.

Authors:  G T Fantry; Q X Zheng; S P James
Journal:  Am J Gastroenterol       Date:  1995-02       Impact factor: 10.864

8.  Single and multiple strain colonization in patients with Helicobacter pylori-associated gastritis: detection by macrorestriction DNA analysis.

Authors:  A M Hirschl; M Richter; A Makristathis; P M Prückl; B Willinger; K Schütze; M L Rotter
Journal:  J Infect Dis       Date:  1994-08       Impact factor: 5.226

9.  Genetic heterogeneity of Helicobacter pylori by pulse-field gel electrophoresis and re-evaluation of DNA homology.

Authors:  S Takami; T Hayashi; H Akashi; T Shimoyama; T Tamura
Journal:  Eur J Gastroenterol Hepatol       Date:  1994-12       Impact factor: 2.566

10.  Pre-formed urease activity of Helicobacter pylori as determined by a viable cell count technique--clinical implications.

Authors:  H X Xia; C T Keane; C A O'Morain
Journal:  J Med Microbiol       Date:  1994-06       Impact factor: 2.472

View more
  24 in total

Review 1.  H pylori recurrence after successful eradication.

Authors:  Yaron Niv
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

Review 2.  How should Helicobacter pylori positive dyspeptic patients be managed?

Authors:  N J Talley
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

3.  Gastric malt lymphoma: Analysis of a series of consecutive patients over 20 years.

Authors:  Joana Moleiro; Sara Ferreira; Pedro Lage; A Dias Pereira
Journal:  United European Gastroenterol J       Date:  2015-10-30       Impact factor: 4.623

Review 4.  Pharmacokinetic considerations in the eradication of Helicobacter pylori.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

Review 5.  Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infection.

Authors:  Qian Ren; Xiang Yan; YongNing Zhou; Wei Xin Li
Journal:  Cochrane Database Syst Rev       Date:  2016-02-07

Review 6.  Helicobacter pylori eradication in West Asia: a review.

Authors:  Hafez Fakheri; Zohreh Bari; Mohsen Aarabi; Reza Malekzadeh
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

Review 7.  A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy.

Authors:  U Peitz; A Hackelsberger; P Malfertheiner
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

8.  Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori infection.

Authors:  Ji-Hyun Shin; Mierha Yang; Seung Woo Nam; Jung Taik Kim; Na Hye Myung; Won-Gi Bang; Im Hwan Roe
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

9.  Does seropositivity for Helicobacter pylori antibodies increase outpatient costs for gastric and duodenal ulcer or inflammation?

Authors:  Akira Babazono; Motonobu Miyazaki; Hiroshi Une; Eiji Yamamoto; Toshihide Tsuda; Yoshio Mino; Alan L Hillman
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 10.  Helicobacter pylori infection in Canadian and related Arctic Aboriginal populations.

Authors:  K J Goodman; K Jacobson; S Veldhuyzen van Zanten
Journal:  Can J Gastroenterol       Date:  2008-03       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.